These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 2128514
21. [Effect of MAO inhibitors on impeding synaptosomal withdrawal and on dopamine metabolism in rat and human brain]. Tóthfalusi L, Tekes K, Gaál J, Magyar K. Acta Pharm Hung; 1989; 59 Suppl 1():75-9. PubMed ID: 2641638 [No Abstract] [Full Text] [Related]
22. The effect of repeated doses of (-) deprenyl on the dynamics of monoaminergic transmission. Comparison with clorgyline. Zsilla G, Földi P, Held G, Székely AM, Knoll J. Pol J Pharmacol Pharm; 1986; 38(1):57-67. PubMed ID: 3020531 [Abstract] [Full Text] [Related]
23. The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J-508: their properties and applications. Fowler CJ, Oreland L, Callingham BA. J Pharm Pharmacol; 1981 Jun; 33(6):341-7. PubMed ID: 6115003 [No Abstract] [Full Text] [Related]
24. The monoamine oxidase inhibitors clorgyline and L-deprenyl also affect the uptake of dopamine, noradrenaline and serotonin by rat brain synaptosomal preparations. Lai JC, Leung TK, Guest JF, Lim L, Davison AN. Biochem Pharmacol; 1980 Oct 15; 29(20):2763-7. PubMed ID: 6776961 [No Abstract] [Full Text] [Related]
25. Effect of MAO inhibitors on the uptake and metabolism of dopamine in rat and human brain. Tekes K, Tóthfalusi L, Gaál J, Magyar K. Pol J Pharmacol Pharm; 1988 Oct 15; 40(6):653-8. PubMed ID: 3152003 [Abstract] [Full Text] [Related]
28. Dopamine produced from L-DOPA is degraded by endogenous monoamine oxidase in neurons of the dorsal raphe nucleus of the rat: an immunohistochemical study. Arai R, Karasawa N, Nagatsu I. Brain Res; 1996 May 25; 722(1-2):181-4. PubMed ID: 8813364 [Abstract] [Full Text] [Related]
31. Adaptative changes of the serotonergic system after antidepressant treatments. Artigas F, Bel N, Casanovas JM, Romero L. Adv Exp Med Biol; 1996 May 25; 398():51-9. PubMed ID: 8906240 [No Abstract] [Full Text] [Related]
32. Role of type A and type B monoamine oxidase in the metabolism of released [3H]dopamine from rat striatal slices. Schoepp DD, Azzaro AJ. Biochem Pharmacol; 1982 Sep 15; 31(18):2961-8. PubMed ID: 6814449 [No Abstract] [Full Text] [Related]
34. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correspondence of its binding sites to monoamine oxidase in rat brain, and inhibition of dopamine oxidative deamination in vivo and in vitro. Bocchetta A, Piccardi MP, Del Zompo M, Pintus S, Corsini GU. J Neurochem; 1985 Sep 15; 45(3):673-6. PubMed ID: 3928808 [Abstract] [Full Text] [Related]
35. Release of endogenous dopamine from rat isolated striatum: effect of clorgyline and (-)-deprenyl. Hársing LG, Vizi ES. Br J Pharmacol; 1984 Nov 15; 83(3):741-9. PubMed ID: 6439273 [Abstract] [Full Text] [Related]
37. Effect of high single doses of levodopa and carbidopa on brain dopamine and its metabolites: modulation by selective inhibitors of monoamine oxidase and/or catechol-O-methyltransferase in the male rat. Männistö PT, Tuomainen P. Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct 10; 344(4):412-8. PubMed ID: 1766471 [Abstract] [Full Text] [Related]